INFLIXIMAB ANTIBODY

Infliximab is a chimeric monoclonal antibody medication used to treat various autoimmune diseases, including Crohns disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, andnBehçets disease.It works by neutralizing Tumor Necrosis Factor - alpha (TNF - alpha), a pro - inflammatory cytokine involved in inflammation.Infliximab is administered by intravenous infusion and is often used in combination with other medications.Common side effects include infections, infusion reactions, and abdominal pain.